Company / Return on Assets (ROA)
Whitehawk Therapeutics, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-42.2%
FY2025
5-year range
-93.5% / -2.2%
FY2021-FY2025
Trend
+54.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -93.5% in FY2024 to -2.2% in FY2021.
Based on SEC 10-K filings.
-42.2% in FY2025 with a 5-year CAGR of +9.6%.
Improved from -45.7% to -42.2% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +17.5pp
- 5-Year Change
- +9.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 54.8% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -42.2% | +54.8% |
| FY2024 | -93.5% | -104.6% |
| FY2023 | -45.7% | +23.5% |
| FY2022 | -59.8% | -2615.9% |
| FY2021 | -2.2% | +95.8% |
| FY2020 | -51.8% | -99.0% |
| FY2019 | -26.0% | +22.0% |
| FY2018 | -33.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026